Arcam buys orthopedic implants maker DiSanto Technology.
3 September 2014 - Swedish provider of industrial 3D-printing solutions Arcam AB (STO:ARCM) announced today it had closed the acquisition of its strategic partner US orthopedic implants manufacturer DiSanto Technology for USD15.8m (EUR12m).
Under the terms of the acquisition deal, the purchase price will be paid in a combination of cash and through Arcam stock options issued to the vendors in February 2013.
DiSanto specialises in engineering, development and production of orthopedic implants and instruments. Over the past year, the company's revenues came in at about USD12m. After the acquisition, DiSanto will be a wholly owned subsidiary of Arcam. According to the buyer, the deal is expected to be accretive to Acram's earnings per share in the current year.
By taking over DiSanto, Arcam will be able to integrate its EBM technology for additive manufacturing with the orthopedic implants production, facilitating market adoption of the technology.
During the transaction, Arcam received financial advice from US investment banking firm Viant Capital LLC.
Target: DiSanto Technology
Buyer: Arcam AB
Deal size in USD: 15.8m
Type: Corporate acquisition
Financing: Cash & Stock
Buyer advisor: Viant Capital LLC
|Printer friendly Cite/link Email Feedback|
|Publication:||M & A Navigator|
|Date:||Sep 3, 2014|
|Previous Article:||TransAtlantic Petroleum agrees to buy Stream Oil & Gas.|
|Next Article:||Breedon Aggregates acquires half of H V Bowen.|